Researchers from Google have reported that their AI can detect and identify 26 skin conditions (as much as a certified American dermatologist determines).

The university has opened a Centre for the study of psychedelics as medications for the treatment of neurological diseases. It was sponsored by Steven and Alexandra Cohen Foundation and four benefactors who raised about $ 17 million.

"Innovative" and "provocative" therapies with mesenchymal stem cells in case of progressive multiple sclerosis have shown good results.

Scientists from Stanford University School of Medicine have reported the success of the world's first complete digital randomized clinical trial. A document showing the results of the work was published in The Lancet Digital Health.

Swedish medicines manufacturer Orexo, best known for its medicines for opioid addiction, has licensed an innovative digital therapy for alcohol addiction.

A blood test for detection of inflammation can foresee an individual risk of developing heart and vascular diseases or early death 40 years before real problems arise. The authors of the development are the scientists of Sloan Kettering Cancer Center.

Scientists have found that Wolbachia bacterium used to fight mosquitoes can be a very cheap and effective way to fight dengue virus.

A group of scientists from NUST MISiS, has created a new material for medical implants that simplifies recovery from fractures, Remedium reports. The secret is to use platinum and iron nanoparticles. They allow to destroy up to 98% of harmful bacteria, as a result to reduce the risk of postoperative infections.

Kadimastem Company from Israeli has reported that the rodent trials of the new IsletRx anti-diabetes drug have been successfully completed. As Xinhua notes, therapy is based on working pancreatic cells and a unique microencapsulation technology. The experiments have proved the safety of the delivery method and the effectiveness of therapy (blood sugar levels were within the normal range).

The University of Northern Carolina has established that mainly cancer develops as a result of the interaction of bacteria and glycoprotein MUC1, which covers the surface of epithelial cells in the body. According to Eurolab, MUC1 is present in almost all glandular epithelial cells.